TABLE 2.
The evaluation parameters for estimating the impact of the observed intra‐fractional shifts of the patient and the tumor on the delivered dose
| Target coverage | |
|---|---|
| Structure | Evaluation parameter |
| GTV | D98% |
| Organs at risk | |
|---|---|
| Structure | Evaluation parameter |
| Spinal cord | D2% |
| Trachea | D2% |
| Bronchial Tree | D2% |
| Esophagus | D2% |
| Heart | D2% |
| Great Vessels | D2% |
| Brachial Plexus | D2% |
| Lungs | V20 Gy; Dmean |
| Ipsilateral lung | Dmean |
| Contralateral lung | Dmean |
| Ribs | D2% |
| Thoracic Wall | V30 Gy; V34 Gy; V45 Gy |
| Skin | D2% |
| Body | D2% |
Note: The examined dose level for the thoracic wall is dependent on the number of fractions that were used for the treatment delivery (i.e. V30 Gy for 3 fractions, V34 Gy for 4 fractions and V45 Gy for 6 or 8 fractions).